beta-Htbz is a stereochemically defined active metabolite of tetrabenazine, characterized by a benzoquinolizine core with dimethoxy and hydroxyl substituents. It is primarily of interest as a pharmaceutical reference standard for research and analytical purposes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 924854-60-4
(2R,3R,11bR)-10-methoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizine-2,9-diol
research compound
Zidovudine triphosphate
pharmaceutical raw material
(EZ)-cefprozil
pharmaceutical raw material
(E)-cefprozil
pharmaceutical raw material
(2S,2'S)-N,N'-{(1S,3R,4S)-4-[(3-Amino-3-deoxy-alpha-D-threo-hexopyranosyl)oxy]-6-[(6-amino-6-deoxy-alpha-D-glycero-hexopyranosyl)oxy]-5-hydroxycyclohexane-1,3-diyl}bis(4-amino-2-hydroxybutanamide)
pharmaceutical raw material
Dihydrotetrabenazine
research compound
Valbenazine
pharmaceutical raw material
Valbenazine ditosylate
pharmaceutical raw material
(2S,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol
WEQLWGNDNRARGE-OIISXLGYSA-N
CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2C[C@@H]1O)OC)OC